|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
SMITH CRAIG R 500 EAST PRATT STREET SUITE 1300 BALTIMORE, MD 21202 |
X |
Gail L. Valenti as Attorney-in-Fact for Craig R. Smith | 06/01/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | These shares were acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $14.30 - $16.11 during the first quarter of 2018. |
(2) | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.14 - $15.19. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
(3) | Shares held of record by Craig Robert Smith, MD, Trustee of the Craig Robert Smith MD REV Trust DTD 3/8/11. |
(4) | Includes shares formerly held directly at the transfer agent that were transferred to the Craig Robert Smith MD REV Trust DTD 3/8/11 (revocable Trust) on May 15, 2018. Effective with the sale that occurred on May 30, 2018 and that was reported on May 31, 2018, Dr. Smith beneficially owns 22,802 total shares indirectly in the revocable Trust, 6,666 shares directly in a tax-deferred individual retirement account (IRA),and a 0.833 fractional share interest at the transfer agent, for a total of 29,468.833 shares. |